Flynn James E 13D and 13G filings for Aerie Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 10:00 am Sale |
2022-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
Flynn James E | 0 0.000% |
-4,695,020 (Position Closed) |
Filing |
| 2022-02-11 4:08 pm Purchase |
2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
Flynn James E | 4,695,020 9.910% |
2,159,519 (+85.17%) |
Filing |
| 2021-08-16 5:06 pm Purchase |
2021-08-04 | 13G | Aerie Pharmaceuticals, Inc. AERI |
Flynn James E | 2,535,501 5.370% |
2,041,285 (+413.03%) |
Filing |
| 2020-06-30 4:35 pm Sale |
2020-06-30 | 13G | Aerie Pharmaceuticals, Inc. AERI |
Flynn James E | 494,216 1.060% |
-2,037,931 (-80.48%) |
Filing |